|1.||Lu, L-H: 1 article (10/2015)|
|2.||Lin, T: 1 article (10/2015)|
|3.||He, Y-R: 1 article (10/2015)|
|4.||Qiu, H-L: 1 article (10/2015)|
|5.||Tu, C-C: 1 article (10/2015)|
|6.||Wagner, Ernst: 1 article (10/2015)|
|7.||An, Sai: 1 article (10/2015)|
|8.||He, Dongsheng: 1 article (10/2015)|
|9.||Jiang, Chen: 1 article (10/2015)|
|10.||Shi, Q-X: 1 article (10/2015)|
02/01/2008 - "These observations encourage further clinical evaluation of the inhibitory effects of octadecenoic acids on various forms of cancer."
01/01/1992 - "Three studies were undertaken to: (1) measure the toxicities of stearic and oleic acids to normal and malignant cells in vitro, (2) assess if there is any relationship between toxicity and relative fatty acid composition and (3) determine whether the relative fatty acid composition of a cancer cell line could be modified by sterculic acid, an inhibitor of delta-9-desaturase. "
09/25/2015 - "Human α-lactalbumin made lethal to tumor cells (HAMLET) is a tumoricidal complex consisting of human α-lactalbumin and multiple oleic acids (OAs). "
01/01/2013 - "HAMLET is a complex of oleic acids and decalcified α-lactalbumin that was discovered to selectively kill tumor cells both in vitro and in vivo. "
01/01/2013 - "HAMLET and ELOA are complexes consisting of oleic acid and two homologous, yet functionally different, proteins with cytotoxic activities against mammalian cells, with HAMLET showing higher tumor cells specificity, possibly due to the difference in propensity for oleic acid binding, as HAMLET binds 5-8 oleic acid molecules per protein molecule and ELOA binds 11-48 oleic acids. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
12/01/2008 - "In our earlier case-control study, colorectal cancer risk showed positive relationships with erythrocyte membrane compositions of palmitic and oleic acids, but negative links with linoleic and arachidonic acids. "
07/15/2007 - "Total and trans-monounsaturated fatty acids and palmitic, stearic, and oleic acids were dose-dependently associated with colorectal cancer risk, but these effects did not persist after further energy adjustment. "
|3.||Experimental Liver Neoplasms
08/01/1972 - "The effect of two isomeric octadecenoic acids on alkyl diacyl glycerides and neutral glycosphingolipids of novikoff hepatoma cells."
09/01/1979 - "The major acyl chain changes found in Morris hepatoma 5123c compared with both normal and host rat livers were: a) a higher percentage of arachidonic acid together with a lower proportion of palmitic acid in cholesteryl esters; b) an increase of stearic and arachidonic acids and a decrease of palmitic acid in triglycerides; and c) a higher level of palmitic and oleic acids associated with a lower percentage of stearic and C22 polyunsaturated acids in phosphatidylcholine."
12/06/2002 - "Ryanodine, which can either accentuate or block Ca(2+) release, significantly enhanced ischemia/reperfusion-elicited efflux of linoleic acid, with non-significant increases in the efflux of myristic, arachidonic, palmitic and oleic acids. "
08/07/1999 - "Hyperglycemia resulted in significantly reduced levels of glutamate, phosphoethanolamine, GABA and arachidonic, myristic, palmitic, linoleic and oleic acids during ischemia/reperfusion in comparison with the saline-injected ischemic controls. "
01/01/2013 - "Liver fatty acids were not altered except for trans-octadecenoic acids, which were increased. "
03/01/1968 - "Nevertheless, most of the total increases in plasma and liver fatty acids were due to the greater accumulations of palmitic, stearic, and oleic acids; the hepatic level of oleate was elevated by 204%. "
|2.||Linoleic Acid (Linoleate)
|3.||Arachidonic Acid (Vitamin F)
|5.||Fatty Acids (Saturated Fatty Acids)
|8.||Oleic Acid (Oleate)